| LDR | 01350cam a2200361Ia 4500 | ||
| 001 | 102122576 | ||
| 003 | MiAaHDL | ||
| 005 | 20170619000000.0 | ||
| 006 | m d | ||
| 007 | cr bn ---auaua | ||
| 007 | cr unu | ||
| 008 | 000612s2000 dcuab b f000 0 eng d | ||
| 035 | ⊔ | ⊔ | ‡asdr-ucr.b2762321x |
| 040 | ⊔ | ⊔ | ‡aUNA ‡cUNA ‡dWOO ‡dOCLCQ |
| 049 | 9 | 9 | ‡aRECLAMATION |
| 086 | 0 | ⊔ | ‡aPREX 26.1/2:2000/COUNTER* |
| 098 | ⊔ | ⊔ | ‡aElectronicbook |
| 098 | ⊔ | ⊔ | ‡aPREX26122000UPDATE |
| 098 | ⊔ | ⊔ | ‡aPREX26122000COUNTER* |
| 099 | ⊔ | 8 | ‡aPREX 26.1/2:2000/UPDATE |
| 035 | ⊔ | ⊔ | ‡a(OCoLC)44389073 |
| 110 | 1 | ⊔ | ‡aUnited States. ‡bOffice of National Drug Control Policy. |
| 245 | 1 | 0 | ‡aNational Drug Control Strategy : ‡bcounterdrug research and development blueprint update : 2000 annual report. |
| 246 | 3 | 3 | ‡a2000 counterdrug research and development blueprint update. |
| 246 | 3 | 0 | ‡a2000 annual report. |
| 246 | 3 | 0 | ‡aCounterdrug research and development blueprint update. |
| 260 | ⊔ | ⊔ | ‡aWashington, D.C. : ‡bOffice of National Drug Control Policy, Executive Office of the President, ‡c[2000] |
| 300 | ⊔ | ⊔ | ‡av, 48 p. : ‡bill., map ; ‡c28 cm. |
| 538 | ⊔ | ⊔ | ‡aMode of access: Internet. |
| 650 | ⊔ | 0 | ‡aDrug abuse ‡zUnited States ‡xPrevention. |
| 650 | ⊔ | 0 | ‡aDrug control ‡zUnited States. |
| CID | ⊔ | ⊔ | ‡a102122576 |
| DAT | 0 | ⊔ | ‡a20020603160049.0 ‡b20170619000000.0 |
| DAT | 1 | ⊔ | ‡a20170616090540.0 ‡b2023-11-12T18:38:29Z |
| DAT | 2 | ⊔ | ‡a2023-11-12T18:30:02Z |
| CAT | ⊔ | ⊔ | ‡aSDR-UCR ‡dIII - MILLENIUM ‡lprepare.pl-004-007 |
| FMT | ⊔ | ⊔ | ‡aBK |
| HOL | ⊔ | ⊔ | ‡0sdr-ucr.b2762321x ‡auc1 ‡bSDR ‡cUCR ‡puc1.31210013754963 ‡sUC ‡1.b2762321x |
| 974 | ⊔ | ⊔ | ‡bUC ‡cUCR ‡d20231112 ‡sgoogle ‡uuc1.31210013754963 ‡y2000 ‡rpd ‡qbib ‡tUS fed doc |